These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3904398)

  • 1. Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine.
    Bajetta E; Buzzoni R; Viviani S; Vaglini M; Nava M; Bonadonna G
    Am J Clin Oncol; 1985 Oct; 8(5):401-5. PubMed ID: 3904398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic chemotherapy of disseminated cutaneous malignant melanoma--a prospective and randomized clinical trial of procarbazine, vindesine and lomustine versus procarbazine, DTIC and lomustine.
    Carmo-Pereira J; Costa FO; Henriques E
    Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1435-9. PubMed ID: 3595669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of advanced non-small-cell lung cancer: a randomized trial of three cis-platin-based chemotherapy regimens.
    Hainsworth JD; Johnson DH; Hande KR; Greco FA
    Am J Clin Oncol; 1989 Aug; 12(4):345-9. PubMed ID: 2547305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial.
    Jungnelius U; Ringborg U; Aamdal S; Mattsson J; Stierner U; Ingvar C; Malmström P; Andersson R; Karlsson M; Willman K; Wist E; Bjelkengren G; Westberg R
    Eur J Cancer; 1998 Aug; 34(9):1368-74. PubMed ID: 9849419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin and vindesine combination chemotherapy for non-small cell lung cancer: a randomized trial comparing two dosages of cisplatin.
    Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tominaga K; Sakurai M; Suga J; Miyaoka H; Sano T; Keicho N
    Jpn J Cancer Res; 1986 Aug; 77(8):782-9. PubMed ID: 3019976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PALA, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma. A pilot study.
    Voigt H; Kleeberg UR
    Cancer; 1984 May; 53(10):2058-62. PubMed ID: 6231091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A phase I-II trial.
    Ringborg U; Jungnelius U; Hansson J; Strander H
    Am J Clin Oncol; 1990 Jun; 13(3):214-7. PubMed ID: 2346126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of cisplatin, vindesine, and dacarbazine in advanced malignant melanoma. A Phase II Study of the EORTC Malignant Melanoma Cooperative Group.
    Verschraegen CF; Kleeberg UR; Mulder J; Rumke P; Truchetet F; Czarnetzki B; Rozencweig M; Thomas D; Suciu S
    Cancer; 1988 Sep; 62(6):1061-5. PubMed ID: 3409184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
    Pfreundschuh MG; Schoppe WD; Fuchs R; Pflüger KH; Loeffler M; Diehl V
    Cancer Treat Rep; 1987 Dec; 71(12):1203-7. PubMed ID: 2446751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and toxicity of "BELD" polychemotherapy in advanced malignant melanoma.
    Cartei G; Ceschia T; Marsilio P; Clocchiatti L; Fasola G; Morandini G; Galletti D; Sibau A
    Tumori; 1989 Jun; 75(3):229-32. PubMed ID: 2475950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin.
    Pectasides D; Yianniotis H; Alevizakos N; Bafaloukos D; Barbounis V; Varthalitis J; Dimitriadis M; Athanassiou A
    Br J Cancer; 1989 Oct; 60(4):627-9. PubMed ID: 2803936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of procarbazine, vincristine and lomustine (POC) chemotherapy in metastatic cutaneous malignant melanoma.
    Samuel LM; Harvey VJ; Mitchell PL; Thompson PI; Mak D; Melville P; Evans BD
    Eur J Cancer; 1994; 30A(14):2054-6. PubMed ID: 7857702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin plus oral etoposide in the treatment of patients with advanced small cell lung cancer. Japan Clinical Oncology Group.
    Asamoto H; Kawahara M; Iwami F; Kuba M; Furuse K; Tamura T; Saijo N; Shimoyama M
    Jpn J Clin Oncol; 1998 Dec; 28(12):745-8. PubMed ID: 9879292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of BELD combination chemotherapy (bleomycin, vindesine, CCNU, and DTIC) in advanced malignant melanoma.
    Young DW; Lever RS; English JS; MacKie RM
    Cancer; 1985 May; 55(9):1879-81. PubMed ID: 2579722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitomycin-C, etoposide, cisplatin, and hexamethylmelamine (MEPH) as a second-line regimen in lung cancer.
    Chahinian AP; Green G; Holland JF
    Am J Clin Oncol; 1984 Oct; 7(5):419-23. PubMed ID: 6439029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cisplatin and vinca alkaloid combination chemotherapy of advanced non-small-cell lung cancer in the aged].
    Teramoto S; Nagase T; Fukuchi Y; Ishida K; Yamaoka M; Matsuse T; Jo C; Orimo H
    Nihon Ronen Igakkai Zasshi; 1990 Nov; 27(6):680-6. PubMed ID: 1964186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease.
    Gobbi PG; Broglia C; Bertè R; Petrilli MP; Molica S; Angrilli F; Iannitto E; Ghirardelli ML; Di Renzo N; Cavanna L; Ascari E
    Haematologica; 2000 Jul; 85(7):722-8. PubMed ID: 10897124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of DLF, CLF and DFM regimens based on platinum compound plus 5-fluorouracil for treatment of advanced esophageal carcinoma].
    Jiang Y; Qiu XH; Yang YX; Zhang SQ; Chen ZM
    Ai Zheng; 2006 Aug; 25(8):1029-34. PubMed ID: 16965688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dacarbazine versus dacarbazine-vindesine in disseminated malignant melanoma: a randomized phase II study.
    Ringborg U; Rudenstam CM; Hansson J; Hafström L; Stenstam B; Strander H
    Med Oncol Tumor Pharmacother; 1989; 6(4):285-9. PubMed ID: 2693850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial with mitomycin-C/ifosfamide versus mitomycin-C/vindesine versus cisplatin/etoposide in advanced non-small-cell lung cancer.
    Gatzemeier U; Heckmayr M; Hossfeld DK; Kaukel E; Koschel G; Neuhauss R
    Am J Clin Oncol; 1991 Oct; 14(5):405-11. PubMed ID: 1659174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.